These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8356986)

  • 21. Effects of Amsterdam needle and syringe exchange.
    Buning EC
    Int J Addict; 1991 Dec; 26(12):1303-11. PubMed ID: 1787023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV/AIDS prevention: problems and approaches to establishing needle exchange programs in rural areas.
    Reilly D
    Aust Health Rev; 1990; 13(2):127-32. PubMed ID: 10170677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing needle exchange operations in a poor Brazilian community.
    Bastos FI; Malta M; Hacker MA; Petersen M; Sudbrack M; Colombo M; Caiaffa WT;
    Subst Use Misuse; 2006; 41(6-7):937-51. PubMed ID: 16809180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens.
    Heimer R; Khoshnood K; Jariwala-Freeman B; Duncan B; Harima Y
    J Infect Dis; 1996 Apr; 173(4):997-1000. PubMed ID: 8603983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993.
    Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles.
    Zule WA; Latypov A; Otiashvili D; Bangel S; Bobashev GV
    Harm Reduct J; 2018 Aug; 15(1):44. PubMed ID: 30170604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).
    Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC
    Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
    Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
    Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A method for evaluating needle exchange programmes.
    Kaplan EH
    Stat Med; 1994 Oct 15-30; 13(19-20):2179-87. PubMed ID: 7846418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. As easy as ESAP. The New York State Expanded Syringe Access Demonstration Program.
    Shotsky WJ; Cooper JG; Klein SJ
    Body Posit; 2003; 16(1):15-7. PubMed ID: 12739507
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of a needle and syringe exchange on a methadone maintenance unit.
    Wolk J; Wodak A; Guinan JJ; Macaskill P; Simpson JM
    Br J Addict; 1990 Nov; 85(11):1445-50. PubMed ID: 2285840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A needle in the haystack--the dire straits of needle exchange in Hungary.
    Gyarmathy VA; Csák R; Bálint K; Bene E; Varga AE; Varga M; Csiszér N; Vingender I; Rácz J
    BMC Public Health; 2016 Feb; 16():157. PubMed ID: 26880660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Options for reducing HIV transmission related to the dead space in needles and syringes.
    Zule WA; Pande PG; Otiashvili D; Bobashev GV; Friedman SR; Gyarmathy VA; Des Jarlais DC
    Harm Reduct J; 2018 Jan; 15(1):3. PubMed ID: 29334973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New report profiles syringe access in California.
    Cohen J
    Can HIV AIDS Policy Law Rev; 2003 Dec; 8(3):43-4. PubMed ID: 15108654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?
    O'Keefe D; McCormack A; Cogger S; Aitken C; Burns L; Bruno R; Stafford J; Butler K; Breen C; Dietze P
    Int J Drug Policy; 2017 Aug; 46():99-106. PubMed ID: 28667880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A model-based estimate of HIV infectivity via needle sharing.
    Kaplan EH; Heimer R
    J Acquir Immune Defic Syndr (1988); 1992; 5(11):1116-8. PubMed ID: 1403641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syringe use and reuse: effects of syringe exchange programs in four cities.
    Heimer R; Khoshnood K; Bigg D; Guydish J; Junge B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S37-44. PubMed ID: 9663622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of injecting drug uses and HIV-1 infection: analysis from needle exchange program.
    Tellado I; Moran N; Vargas Vidot J; Yamamura Y
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1091-6. PubMed ID: 9449543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.